These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35271704)

  • 1. Severe Acute Respiratory Syndrome Coronavirus 2 Delta Vaccine Breakthrough Transmissibility in Alachua County, Florida.
    Rife Magalis B; Rich S; Tagliamonte MS; Mavian C; Cash MN; Riva A; Marini S; Amador DM; Zhang Y; Shapiro J; Horine A; Starostik P; Pieretti M; Vega S; Paula Lacombe A; Salinas J; Stevenson M; Myers P; Glenn Morris J; Lauzardo M; Prosperi M; Salemi M
    Clin Infect Dis; 2022 Oct; 75(9):1618-1627. PubMed ID: 35271704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated Individuals.
    Caserta LC; Martins M; Cronk B; Anderson R; Eldridge H; Gallow D; Kruppa F; Plocharczyk E; Diel DG
    Microbiol Spectr; 2022 Oct; 10(5):e0056322. PubMed ID: 36165775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.
    Singanayagam A; Hakki S; Dunning J; Madon KJ; Crone MA; Koycheva A; Derqui-Fernandez N; Barnett JL; Whitfield MG; Varro R; Charlett A; Kundu R; Fenn J; Cutajar J; Quinn V; Conibear E; Barclay W; Freemont PS; Taylor GP; Ahmad S; Zambon M; Ferguson NM; Lalvani A;
    Lancet Infect Dis; 2022 Feb; 22(2):183-195. PubMed ID: 34756186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
    ; Thompson MG; Yoon SK; Naleway AL; Meece J; Fabrizio TP; Caban-Martinez AJ; Burgess JL; Gaglani M; Olsho LEW; Bateman A; Lundgren J; Grant L; Phillips AL; Groom HC; Stefanski E; Solle NS; Ellingson K; Lutrick K; Dunnigan K; Wesley MG; Guenther K; Hunt A; Mak J; Hegmann KT; Kuntz JL; Bissonnette A; Hollister J; Rose S; Morrill TC; Respet K; Fowlkes AL; Thiese MS; Rivers P; Herring MK; Odean MJ; Yoo YM; Brunner M; Bedrick EJ; Fleary DE; Jones JT; Praggastis J; Romine J; Dickerson M; Khan SM; Lamberte JM; Beitel S; Webby RJ; Tyner HL
    JAMA; 2022 Oct; 328(15):1523-1533. PubMed ID: 36255426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021.
    Marques AD; Sherrill-Mix S; Everett JK; Reddy S; Hokama P; Roche AM; Hwang Y; Glascock A; Whiteside SA; Graham-Wooten J; Khatib LA; Fitzgerald AS; Moustafa AM; Bianco C; Rajagopal S; Helton J; Deming R; Denu L; Ahmed A; Kitt E; Coffin SE; Newbern C; Mell JC; Planet PJ; Badjatia N; Richards B; Wang ZX; Cannuscio CC; Strelau KM; Jaskowiak-Barr A; Cressman L; Loughrey S; Ganguly A; Feldman MD; Collman RG; Rodino KG; Kelly BJ; Bushman FD
    mBio; 2021 Feb; 13(1):e0378821. PubMed ID: 35130727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals.
    Huai Luo C; Paul Morris C; Sachithanandham J; Amadi A; Gaston DC; Li M; Swanson NJ; Schwartz M; Klein EY; Pekosz A; Mostafa HH
    Clin Infect Dis; 2022 Aug; 75(1):e715-e725. PubMed ID: 34922338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients.
    Plante JA; Machado RRG; Mitchell BM; Shinde DP; Walker J; Scharton D; McConnell A; Saada N; Liu J; Khan B; Campos RK; Johnson BA; Menachery VD; Levine CB; Ren P; McLellan SLF; Plante KS; Weaver SC
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak at a College With High Coronavirus Disease 2019 (COVID-19) Vaccination Coverage-Connecticut, August 2021-September 2021.
    Bart SM; Curtiss CC; Earnest R; Lobe-Costonis R; Peterson H; McWilliams C; Billig K; Hadler JL; Grubaugh ND; Arcelus VJ; Sosa LE
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S243-S250. PubMed ID: 35675696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.
    Zhang M; Liang Y; Yu D; Du B; Cheng W; Li L; Yu Z; Luo S; Zhang Y; Wang H; Zhang X; Zhang W
    Int J Biol Sci; 2022; 18(2):889-900. PubMed ID: 35002532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA.
    Keyel AC; Russell A; Plitnick J; Rowlands JV; Lamson DM; Rosenberg E; St George K
    Emerg Infect Dis; 2022 Oct; 28(10):1990-1998. PubMed ID: 36048774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends and Correlates of Breakthrough Infections With SARS-CoV-2.
    Yamal JM; Appana S; Wang M; Leon-Novelo L; Bakota E; Ye Y; Sharma S; Morrison AC; Marko D; Linder SH; Rector A; Jetelina KK; Boerwinkle E; de Oliveira Otto M
    Front Public Health; 2022; 10():856532. PubMed ID: 35619825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA loads of severe acute respiratory syndrome coronavirus 2 in patients with breakthrough coronavirus disease 2019 caused by the Delta and Omicron variants.
    de Michelena P; Torres I; Ferrando EC; Olea B; González-Candelas F; Sánchez G; Navarro D
    Clin Microbiol Infect; 2023 Feb; 29(2):256.e1-256.e4. PubMed ID: 36115649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
    Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
    Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.
    Puhach O; Adea K; Hulo N; Sattonnet P; Genecand C; Iten A; Jacquérioz F; Kaiser L; Vetter P; Eckerle I; Meyer B
    Nat Med; 2022 Jul; 28(7):1491-1500. PubMed ID: 35395151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
    Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
    J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-frequency variants in mildly symptomatic vaccine breakthrough infections presents a doubled-edged sword.
    Magalis BR; Mavian C; Tagliamonte M; Rich SN; Cash M; Riva A; Loeb JC; Norris M; Amador DM; Zhang Y; Shapiro J; Starostik P; Marini S; Myers P; Ostrov DA; Lednicky JA; Glenn Morris J; Lauzardo M; Salemi M
    J Med Virol; 2022 Jul; 94(7):3192-3202. PubMed ID: 35307848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study.
    Gazit S; Shlezinger R; Perez G; Lotan R; Peretz A; Ben-Tov A; Herzel E; Alapi H; Cohen D; Muhsen K; Chodick G; Patalon T
    Clin Infect Dis; 2022 Aug; 75(1):e545-e551. PubMed ID: 35380632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
    Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
    JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.